The role of IL18-607C > A and IL18-137G > C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report

Neuroscience Letters

Volumn 622, Issue , 2016, Pages 107-112

  Santos, Marlene ^a,b,c   Carvalho, Serafim ^d,e   Lima, Luís ^a,b   Mota Pereira, Jorge ^f   Pimentel, Paulo ^g   Maia, Dulce ^g   Correia, Diana ^d   Gomes, Sofia ^d   Cruz, Agostinho ^b   Medeiros, Rui ^a,h,i,j  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d Institute of Biomedical Sciences Abel Salazar   (Portugal)

^e UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^f Clínica Médico Psiquiátrica da Ordem   (Portugal)

^g Trás os Montes e Alto Douro Central Hospital   (Portugal)

^h UNIVERSITY OF PORTO   (Portugal)

ⁱ UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^j Portuguese League Against Cancer (Norte)   (Portugal)

more..

Author keywords

Antidepressants; Cytokines; Genetic polymorphisms; IL18; Relapse

Indexed keywords

ANTIDEPRESSANT AGENT; INTERLEUKIN 18; MESSENGER RNA;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FREQUENCY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOUSEKEEPING GENE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; PORTUGAL; PRIORITY JOURNAL; PROMOTER REGION; RELAPSE; REMISSION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; UPREGULATION; ADOLESCENT; DEPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; MIDDLE AGED; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECURRENCE; RNA, MESSENGER; YOUNG ADULT;

EID: 84967185449     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.03.026     Document Type: Article

References (26)

1. Lepine J.P., Briley M. The increasing burden of depression. Neuropsychiatr. Dis. Treat. 2011, 7:3-7.
2. Kato M., Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry 2010, 15:473-500.
3. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
4. Kokai M., Kashiwamura S., Okamura H., Ohara K., Morita Y. Plasma interleukin-18 levels in patients with psychiatric disorders. J. Immunother 2002, 25(Suppl. (1)):S68-S71.
5. Merendino R.A., Di Rosa A.E., Di Pasquale G., Minciullo P.L., Mangraviti C., Costantino A., et al. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm. 2002, 11:265-267.
6. Alboni S., Cervia D., Sugama S., Conti B. Interleukin 18 in the CNS. J. Neuroinflammation 2010, 7:9.
7. Wheeler R.D., Culhane A.C., Hall M.D., Pickering-Brown S., Rothwell N.J., Luheshi G.N. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res. Mol. Brain Res. 2000, 77:290-293.
8. Wang N., Sugama S., Conti B., Teramoto A., Shibasaki T. Interleukin-18 mRNA expression in the rat pituitary gland. J. Neuroimmunol. 2006, 173:117-125.
9. Conti B., Park L.C., Calingasan N.Y., Kim Y., Kim H., Bae Y., et al. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res. 1999, 67:46-52.
10. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 2011, 16:751-762.
11. Alboni S., Benatti C., Montanari C., Tascedda F., Brunello N. Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus. Eur. J. Pharmacol. 2013, 721:158-167.
12. Giedraitis V., He B., Huang W.X., Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J. Neuroimmunol. 2001, 112:146-152.
13. Bossu P., Salani F., Cacciari C., Picchetto L., Cao M., Bizzoni F., et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr. Neurovasc. Res. 2009, 6:163-170.
14. Haastrup E., Bukh J.D., Bock C., Vinberg M., Thorner L.W., Hansen T., et al. Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events. J. Affect. Disord. 2012, 136:134-138.
15. Santos M., Carvalho S., Lima L., Mota-Pereira J., Pimentel P., Maia D., et al. FAS -670A > G genetic polymorphism is associated with treatment resistant depression. J. Affect. Disord. 2015, 185:164-169.
16. Carvalho S.A.D. Variáveis Sócio-Cognitivas Como Preditores Da Resposta Ao Tratamento Farmacológico Da Depressão. Vol. Tese De Doutoramento 2012, Universidade de Coimbra, Coimbra.
17. Trivedi M.H., Rush A.J., Crismon M.L., Kashner T.M., Toprac M.G., Carmody T.J., et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 2004, 61:669-680.
18. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic acids research 2002, 30:e36.
19. Kroes R.A., Panksepp J., Burgdorf J., Otto N.J., Moskal J.R. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 2006, 137:37-49.
20. Al-Hakeim H.K., Al-Rammahi D.A., Al-Dujaili A.H. IL-6, IL-18, sIL-2R, and TNFalpha proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J. Affect. Disord. 2015, 182:106-114.
21. Khripko O.P., Sennikova N.S., Lopatnikova J.A., Khripko J.I., Filipenko M.L., Khrapov E.A., et al. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators Inflamm 2008, 2008:309721.
22. Iwata M., Ota K.T., Duman R.S. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain. behav. immun. 2013, 31:105-114.
23. Jo E.K., Kim J.K., Shin D.M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol. Immunol. 2015.
24. Prossin A.R., Koch A.E., Campbell P.L., Barichello T., Zalcman S.S., Zubieta J.K. Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction. Mol. Psychiatry 2015, 21(2):243-251.
25. Sugama S., Conti B. Interleukin-18 and stress. Brain Res. Rev. 2008, 58:85-95.
26. Alboni S., Montanari C., Benatti C., Sanchez-Alavez M., Rigillo G., Blom J.M., et al. Interleukin 18 activates MAPKs and STAT3 but not NF-kappaB in hippocampal HT-22 cells. Brain behav immun. 2014, 40:85-94.